Two rare cases of benign hyperlipasemia in children

Elena Lionetti1, Ruggiero Francavilla1, Salvatore Leonardi1

  • 1Elena Lionetti, Salvatore Leonardi, Stefania Tomarchio, Alessia Gennaro, Chiara Franzonello, Mario La Rosa, Department of Medical and Pediatric Science, University of Catania, 95123 Catania, Italy.

Insights

Gullo's syndrome, a condition with elevated lipase without pancreatic disease, is described in two children. This benign, non-familial hyperlipasemia highlights a rare pediatric condition.

Area of Science:

  • Pediatric Gastroenterology
  • Biochemistry
  • Endocrinology

Background:

  • Gullo's syndrome is a recently identified condition characterized by chronic elevation of pancreatic enzymes, specifically amylase and/or lipase, without evidence of pancreatic disease.
  • Previously, only one case of benign isolated hyperlipasemia in pediatric patients had been documented, making further case studies crucial for understanding this rare syndrome.

Observation:

  • This report details two pediatric cases presenting with benign, non-familial elevations in serum lipase.
  • Case 1 involved a 6-year-old girl with incidentally discovered, fluctuating hyperlipasemia (193 U/L) over two years, with normal pancreatic imaging and negative genetic testing for pancreatitis.
  • Case 2 described an 8-year-old girl with symptoms of nausea, vomiting, and abdominal pain, who exhibited elevated serum lipase (96 U/L) and normal pancreatic diagnostics, eventually becoming asymptomatic despite persistent high lipase levels.

Findings:

  • Both pediatric patients exhibited elevated serum lipase levels significantly above the normal range (0-60 U/L).
  • Extensive diagnostic workups, including genetic screening, autoimmune markers, infectious disease panels, and various imaging techniques (ultrasound, MRI, CT), ruled out underlying pancreatic diseases or other common causes for hyperlipasemia.
  • The observed hyperlipasemia in both cases was benign, non-familial, and did not correlate with clinical signs of pancreatic pathology, suggesting a distinct clinical entity.

Implications:

  • These cases expand the known spectrum of Gullo's syndrome in pediatric populations, emphasizing its benign and non-familial nature.
  • The findings suggest that persistent, isolated hyperlipasemia in children, even with transient symptoms, may not indicate significant pancreatic disease and warrants careful, long-term observation.
  • Further research is needed to elucidate the pathophysiology and long-term prognosis of Gullo's syndrome to establish definitive diagnostic and management guidelines.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.0K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
854
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
73.4K